FAM3D inhibits glucagon secretion via MKP1-dependent suppression of ERK1/2 signaling

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cell Biology and Toxicology

• Publication date

  2017-02-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10565-017-9387-8PMID 28247283
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fam3c modulates osteogenic differentiation by down-regulating Runx2.

  2017cited by this paper
• Identification of FAM3D as a new endogenous chemotaxis agonist for the formyl peptide receptors

  2016influential reference
• Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature

  2014cited by this paper
• Pharmacokinetics and Clinical Use of Incretin-Based Therapies in Patients with Chronic Kidney Disease and Type 2 Diabetes

  2014cited by this paper
• Global estimates of diabetes prevalence for 2013 and projections for 2035.

  2014influential reference
• FAM3A promotes vascular smooth muscle cell proliferation and migration and exacerbates neointima formation in rat artery after balloon injury.

  2014cited by this paper
• FAM3A activates PI3K p110α/Akt signaling to ameliorate hepatic gluconeogenesis and lipogenesis

  2014cited by this paper
• Two Dipolar α-Helices within Hormone-encoding Regions of Proglucagon Are Sorting Signals to the Regulated Secretory Pathway*

  2014cited by this paper
• Glucagon and Type 2 Diabetes: the Return of the Alpha Cell

  2014influential reference
• Glucagon regulates hepatic kisspeptin to impair insulin secretion.

  2014cited by this paper
• The role of glucagon on type 2 diabetes at a glance

  2014cited by this paper
• Lysophosphatidic acid stimulation of NHE3 exocytosis in polarized epithelial cells occurs with release from NHERF2 via ERK-PLC-PKCδ signaling.

  2014cited by this paper
• The Multifaceted Proprotein Convertases: Their Unique, Redundant, Complementary, and Opposite Functions*

  2013cited by this paper
• Oit1/Fam3D, a gut-secreted protein displaying nutritional status-dependent regulation.

  2012cited by this paper
• DUSPs, to MAP kinases and beyond

  2012cited by this paper
• Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases

  2012cited by this paper
• Metabolic manifestations of insulin deficiency do not occur without glucagon action

  2012cited by this paper
• Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases

  2011cited by this paper
• Hyperglucagonemia precedes a decline in insulin secretion and causes hyperglycemia in chronically glucose-infused rats.

  2011cited by this paper
• The role of dysregulated glucagon secretion in type 2 diabetes

  2011cited by this paper
• Dynamic Modulation of Prohormone Convertase 2 (PC2)-mediated Precursor Processing by 7B2 Protein

  2011cited by this paper
• Ghrelin directly stimulates glucagon secretion from pancreatic alpha-cells.

  2011cited by this paper
• The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes.

  2011cited by this paper
• Pancreatic‐derived factor promotes lipogenesis in the mouse liver: Role of the Forkhead box 1 signaling pathway

  2011cited by this paper
• The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions.

  2010cited by this paper
• The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action

  2010cited by this paper
• MAPK signaling to the early secretory pathway revealed by kinase/phosphatase functional screening

  2010cited by this paper
• Glucagon and glucagon-like peptides 1 and 2.

  2010cited by this paper
• Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.

  2009cited by this paper
• ERK activation is only one role of PKC in TCR-independent cytotoxic T cell granule exocytosis.

  2008cited by this paper
• Proprotein convertases: lessons from knockouts

  2006cited by this paper
• Mechanisms of glucose-induced secretion of pancreatic-derived factor (PANDER or FAM3B) in pancreatic beta-cells.

  2005cited by this paper
• Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers

  2005cited by this paper
• Glucagon stimulates exocytosis in mouse and rat pancreatic alpha-cells by binding to glucagon receptors.

  2005cited by this paper
• Structure and regulation of MAPK phosphatases.

  2004cited by this paper
• Pancreatic-derived factor (FAM3B), a novel islet cytokine, induces apoptosis of insulin-secreting beta-cells.

  2003cited by this paper
• Cloning, expression, and initial characterization of a novel cytokine-like gene family.

  2002cited by this paper
• The glucagon-like peptides.

  1999cited by this paper
• Differential Processing of Proglucagon by the Subtilisin-like Prohormone Convertases PC2 and PC3 to Generate either Glucagon or Glucagon-like Peptide (*)

  1995cited by this paper
• Proglucagon is processed to glucagon by prohormone convertase PC2 in alpha TC1-6 cells.

  1994cited by this paper
• The effect of circulating growth hormone-binding protein on metabolic clearance, distribution, and degradation of human growth hormone.

  1987cited by this paper
• 0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(5):2078–2084 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-031907 Inhibition of Dipeptidyl Peptidase-4 Reduces Glycemia, Sustains Insulin Levels

  year unknowninfluential reference

• The role of ERK1/2 signaling in diabetes: pathogenic and therapeutic implications

  2025cites this paper
• Jiaotai pill and its main component enhance islet hormone secretion in type 2 diabetic rats by activating the THP1/TGase2/SERT/5-HT1FR pathway

  2025cites this paper
• Hepatocyte-secreted FAM3D ameliorates hepatic steatosis by activating FPR1-hnRNP U-GR-SCAD pathway to enhance lipid oxidation.

  2023cites this paper
• The Potential Mechanism of Zishen Yutai Pills against Threatened Abortion: An Approach Involving Network Pharmacology and Experimental Evidence

  2023cites this paper
• FAM3D as a Prognostic Indicator of Head and Neck Squamous Cell Carcinoma Is Associated with Immune Infiltration

  2022cites this paper
• FAM3D inhibits gluconeogenesis in high glucose environment via DUSP1/ZFP36/SIK1 axis

  2022cites this paper
• FAM3D levels in women with gestational diabetes

  2022cites this paper
• Impact of the Glycemic Level on the Salivary Proteome of Middle-Aged and Elderly People With Type 2 Diabetes Mellitus: An Observational Study

  2021cites this paper
• FAM3C in Alzheimer's disease

  2020cites this paper
• ROCK2 disturbs MKP1 expression to promote invasion and metastasis in hepatocellular carcinoma.

  2020cites this paper
• The preprohormone expression profile of enteroendocrine cells following Roux-en-Y gastric bypass in rats.

  2019cites this paper
• The cardenolides ouabain and reevesioside A promote FGF2 secretion and subsequent FGFR1 phosphorylation via converged ERK1/2 activation.

  2019cites this paper
• Inhibition of PTP1B Promotes M2 Polarization via MicroRNA-26a/MKP1 Signaling Pathway in Murine Macrophages

  2019cites this paper
• Chemotactic Ligands that Activate G-Protein-Coupled Formylpeptide Receptors

  2019cites this paper
• Effect of Total Flavones from Cuscuta Chinensis on Anti-Abortion via the MAPK Signaling Pathway

  2018cites this paper
• Mitochondrial DNA Methylation and Related Disease.

  2017cites this paper